M 
Modern Healthcare Technology Holdings 919.HK · HKD
Consumer Discretionary · HKEX · 🇭🇰 Hong Kong
0.08
0.00%
Close of 4 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in HKD, from our data supplier.
Revenue
HK$453.3m
FY2016FY2025
Net income
−HK$5.1m
FY2016FY2025
Free cash flow
HK$134.9m
FY2016FY2025
Shareholders' equity
HK$185.8m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | HK$453.3m | HK$454.7m | HK$406.3m | HK$355.6m | HK$431.5m | HK$522.6m | HK$576.0m | HK$599.0m | HK$693.3m | HK$775.4m |
| Gross profit | HK$436.9m | HK$440.2m | HK$394.7m | HK$341.5m | HK$417.7m | HK$503.7m | HK$551.9m | HK$575.7m | HK$670.9m | HK$750.6m |
| Operating income | HK$2.0m | −HK$7.0m | −HK$37.6m | −HK$74.7m | HK$63.3m | −HK$17.8m | −HK$2.3m | −HK$26.5m | HK$45.2m | HK$11.5m |
| Net income | −HK$5.1m | −HK$9.6m | −HK$20.6m | −HK$68.8m | HK$125.7m | −HK$31.6m | −HK$13.3m | −HK$22.9m | HK$33.3m | HK$10.4m |
| Diluted earnings per share | -0.01 | -0.01 | -0.02 | -0.08 | 0.14 | -0.03 | -0.01 | -0.03 | 0.04 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | HK$564.5m | HK$611.0m | HK$561.3m | HK$571.0m | HK$669.0m | HK$620.0m | HK$579.5m | HK$610.9m | HK$655.6m | HK$816.6m |
| Cash and short-term investments | HK$236.7m | HK$193.7m | HK$177.5m | HK$127.5m | HK$234.3m | HK$179.9m | HK$188.2m | HK$187.2m | HK$249.8m | HK$366.7m |
| Total liabilities | HK$378.6m | HK$421.7m | HK$361.6m | HK$351.4m | HK$379.7m | HK$473.2m | HK$398.2m | HK$525.1m | HK$532.8m | HK$744.1m |
| Debt | HK$68.6m | HK$106.6m | HK$40.1m | HK$65.0m | HK$115.1m | HK$80.9m | — | — | — | HK$91.4m |
| Shareholders' equity | HK$185.8m | HK$189.3m | HK$199.8m | HK$219.6m | HK$289.4m | HK$146.8m | HK$181.3m | HK$85.8m | HK$122.8m | HK$72.5m |
| Shares outstanding | 904m | 904m | 904m | 904m | 904m | 904m | 904m | 904m | 904m | 874m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | HK$151.1m | HK$78.7m | HK$139.8m | HK$51.3m | HK$123.9m | HK$63.9m | HK$33.5m | −HK$26.0m | −HK$36.6m | HK$15.0m |
| Capital spending | −HK$16.1m | −HK$14.6m | −HK$14.3m | −HK$80.9m | −HK$2.2m | −HK$20.0m | −HK$32.6m | −HK$21.3m | −HK$1.3m | −HK$20.8m |
| Free cash flow | HK$134.9m | HK$64.1m | HK$125.5m | −HK$29.5m | HK$121.6m | HK$43.9m | HK$937,000 | −HK$47.4m | −HK$37.8m | −HK$5.8m |
| Dividends paid | — | — | — | — | — | — | — | −HK$11.3m | −HK$14.0m | −HK$21.9m |
Latest quarters
By quarter end
| Sept 2025 | Mar 2025 | Sept 2024 | Mar 2024 | Sept 2023 | Mar 2023 | Sept 2022 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | HK$222.7m | HK$229.0m | HK$224.2m | HK$243.4m | HK$211.3m | HK$180.7m | HK$225.6m | HK$150.2m |
| Gross profit | HK$215.2m | HK$222.1m | HK$214.7m | HK$234.5m | HK$205.7m | HK$174.5m | HK$220.2m | HK$143.7m |
| Operating income | HK$8.2m | HK$12.2m | −HK$10.2m | HK$22.7m | −HK$29.6m | −HK$61.6m | HK$24.0m | −HK$37.9m |
| Net income | HK$6.5m | HK$11.2m | −HK$16.3m | HK$19.2m | −HK$28.8m | −HK$61.3m | HK$40.7m | −HK$26.9m |
| Diluted earnings per share | 0.01 | 0.01 | -0.02 | 0.02 | -0.03 | -0.07 | 0.04 | -0.03 |
| Total assets | HK$561.8m | HK$564.5m | HK$585.7m | HK$611.0m | HK$630.7m | HK$561.3m | HK$584.9m | HK$571.0m |
| Cash and short-term investments | HK$248.5m | HK$236.7m | HK$190.9m | HK$193.7m | HK$204.7m | HK$177.5m | HK$146.9m | HK$127.5m |
| Debt | HK$25.3m | HK$17.9m | HK$32.9m | HK$50.3m | HK$62.5m | HK$14.3m | HK$16.2m | HK$8.6m |
| Shareholders' equity | HK$194.0m | HK$185.8m | HK$175.1m | HK$189.3m | HK$169.5m | HK$199.8m | HK$258.1m | HK$219.6m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.4% | -2.8% | -6.4% |
| Operating income | — | — | -31.0% |
| Net income | -58.1% | -30.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 96.6% | 96.6% | 96.6% | 96.5% |
| Operating margin | -0.5% | -7.0% | -2.7% | 0.6% |
| Net margin | -1.6% | -6.2% | -0.4% | 1.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -13.4 | -7.8 | -3.9 | -2.0 | 1.3 | -2.8 | -9.7 | -7.8 | 7.3 | 31.2 |
| Price to sales | 0.1 | 0.2 | 0.2 | 0.4 | 0.4 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 31 Aug 2017.
| FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.013 | 0.016 | 0.025 | 0.02 | 0.025 | 0.001 | 0.001 | 0.014 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.